01/08/2009
Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' (EurekAlert!)
( University of California - San Diego ) Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others.
MORE INFO
|
01/08/2009
Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' (PhysOrg)
Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others. Armed with a new two-year grant for $600,000 from the Gateway for Cancer Research, an Illinois-based philanthropic foundation, ...
MORE INFO
|
01/08/2009
Supplementation With Vitamin E Or Selenium Does Not Reduce Risk Of Prostate Cancer (Medical News Today)
In perhaps the largest cancer chemoprevention trial ever conducted, researchers have found that supplementation with vitamin E or selenium, alone or in combination, was not associated with a lower risk of prostate cancer or other cancers.
MORE INFO
|
01/07/2009
Free Prostate Cancer Screenings (FOX 12 Idaho)
Free screenings for prostate cancer happening Thursday, January 8th.
MORE INFO
|
01/07/2009
Rising PSA In Nonmetastatic Prostate Cancer (Medical News Today)
Rising prostate-specific antigen (PSA) in nonmetastatic prostate cancer occurs in two main clinical settings: (1) rising PSA to signal failed initial local therapy and (2) rising PSA in the setting of early hormone-refractory prostate cancer prior to documented clinical metastases.
MORE INFO
|
01/07/2009
Vitamin E not effective against prostate cancer, London researchers find (London Free Press)
An international study that involved 1,000 men from the London area has found that Vitamin E fails to reduce the chance of developing prostate cancer.
MORE INFO
|
01/07/2009
FDA Approves Drug For Patients With Advanced Prostate Cancer (Medical News Today)
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors.
MORE INFO
|
01/07/2009
Neither Vitamin C or E Associated with Reduced Risk of Prostate Cancer, or Other Cancers (Kansas City InfoZine)
In a major cancer prevention study, long-term supplementation with vitamin E or C did not reduce the risk of prostate or other cancers for nearly 15,000 male physicians.
MORE INFO
|
01/09/2009
Demand For All Inclusive Prostate Cancer Care Treatment Centers In High Demand Among Urologists Who Diagnose Prostate ... (PRWeb)
Oncology Med, Inc. (Pink Sheets "ONCO") Oncology Med, a Pittsburgh based cancer treatment solutions group, today unveiled its full turnkey cancer center investor model for urology investor physicians, as well as, other interested parties. (PRWeb Jan 9, 2009) Read the full story at http://www.prweb.com/releases/2009/01/prweb1837054.htm
MORE INFO
|
01/06/2009
Study supports pomegranate’s anti-prostate cancer potential (Nutraingredients.com)
Researchers from the University of California, Los Angeles report that extracts of the fruit were associated with a two-fold suppression in the expression of genes linked to prostate cancer.
MORE INFO
|